MARCUZZI, Annalisa
 Distribuzione geografica
Continente #
NA - Nord America 5.898
AS - Asia 3.310
EU - Europa 1.670
SA - Sud America 697
Continente sconosciuto - Info sul continente non disponibili 200
AF - Africa 87
OC - Oceania 2
Totale 11.864
Nazione #
US - Stati Uniti d'America 5.734
SG - Singapore 1.289
CN - Cina 715
BR - Brasile 546
PL - Polonia 476
VN - Vietnam 420
IT - Italia 414
HK - Hong Kong 315
BD - Bangladesh 156
FR - Francia 155
DE - Germania 126
GB - Regno Unito 111
RU - Federazione Russa 96
ID - Indonesia 82
CA - Canada 71
JP - Giappone 67
IN - India 64
AR - Argentina 59
UA - Ucraina 55
FI - Finlandia 50
SE - Svezia 50
TR - Turchia 49
MX - Messico 46
ZA - Sudafrica 38
NL - Olanda 36
AT - Austria 23
IQ - Iraq 20
CO - Colombia 18
ES - Italia 17
EC - Ecuador 16
PK - Pakistan 16
CL - Cile 15
MY - Malesia 15
UZ - Uzbekistan 15
VE - Venezuela 15
AE - Emirati Arabi Uniti 12
JM - Giamaica 12
IE - Irlanda 11
PH - Filippine 10
PY - Paraguay 10
SA - Arabia Saudita 9
BO - Bolivia 8
CZ - Repubblica Ceca 8
DO - Repubblica Dominicana 8
KE - Kenya 8
MA - Marocco 8
BE - Belgio 7
CR - Costa Rica 7
HN - Honduras 7
LT - Lituania 7
NP - Nepal 7
TH - Thailandia 7
TN - Tunisia 6
AZ - Azerbaigian 5
EG - Egitto 5
SN - Senegal 5
UY - Uruguay 5
BA - Bosnia-Erzegovina 4
CH - Svizzera 4
DZ - Algeria 4
IL - Israele 4
JO - Giordania 4
KG - Kirghizistan 4
KZ - Kazakistan 4
RO - Romania 4
TW - Taiwan 4
CI - Costa d'Avorio 3
ET - Etiopia 3
KR - Corea 3
OM - Oman 3
PE - Perù 3
PS - Palestinian Territory 3
SV - El Salvador 3
AL - Albania 2
AO - Angola 2
BY - Bielorussia 2
DK - Danimarca 2
GA - Gabon 2
GP - Guadalupe 2
GR - Grecia 2
GT - Guatemala 2
GY - Guiana 2
HU - Ungheria 2
MD - Moldavia 2
PT - Portogallo 2
TT - Trinidad e Tobago 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AU - Australia 1
BB - Barbados 1
BG - Bulgaria 1
BH - Bahrain 1
BS - Bahamas 1
BW - Botswana 1
EU - Europa 1
GE - Georgia 1
KH - Cambogia 1
KW - Kuwait 1
LB - Libano 1
LV - Lettonia 1
MN - Mongolia 1
Totale 11.659
Città #
Ashburn 849
Fairfield 685
Singapore 681
Warsaw 472
San Jose 409
Woodbridge 356
Santa Clara 332
Hong Kong 309
Seattle 273
Beijing 272
Houston 266
Cambridge 240
Wilmington 207
Council Bluffs 156
Dallas 152
Ho Chi Minh City 140
Hanoi 100
Los Angeles 90
New York 86
Ann Arbor 85
Ferrara 80
Lauterbourg 76
Princeton 73
Tokyo 62
Jakarta 60
Chandler 59
Chicago 59
São Paulo 55
San Diego 48
Moscow 45
Shanghai 40
Milan 39
Jacksonville 38
London 38
Munich 38
Orem 29
Buffalo 27
Nuremberg 26
Helsinki 25
Montreal 25
Mexico City 24
Rio de Janeiro 23
Atlanta 22
Brooklyn 21
Dong Ket 20
Johannesburg 20
Bologna 19
Denver 19
Haiphong 19
Toronto 18
Chennai 17
Jinan 17
Nanjing 17
Boardman 16
Manchester 16
Amsterdam 15
Frankfurt am Main 15
Rome 14
Stockholm 14
Tashkent 14
Da Nang 13
Poplar 13
Salt Lake City 13
Aprilia 12
Hải Dương 12
Izmir 12
Boydton 11
Brasília 11
Changsha 11
Falls Church 11
Ankara 10
Boston 10
Istanbul 10
Phoenix 10
Shenyang 10
Belo Horizonte 9
Campinas 9
Dublin 9
Elk Grove Village 9
Figino 9
Kingston 9
Miami 9
Mumbai 9
Paris 9
Perugia 9
Redwood City 9
San Francisco 9
The Dalles 9
Turku 9
Assago 8
Baghdad 8
Columbus 8
Lappeenranta 8
Las Vegas 8
Milwaukee 8
Norwalk 8
Verona 8
Buenos Aires 7
Curitiba 7
Hebei 7
Totale 7.842
Nome #
Antibodies reacting to mimotopes of Simian virus 40 large T antigen, the viral oncoprotein, in sera from children 448
Neuronal dysfunction associated with cholesterol deregulation 270
Cytokine levels in the serum of healthy subjects 238
Type I interferon-mediated autoinflammation due to DNase II deficiency 228
Geranylgeraniol and Neurological Impairment: Involvement of Apoptosis and Mitochondrial Morphology 218
Lovastatin dose-dependently potentiates the pro-inflammatory activity of lipopolysaccharide both in vitro and in vivo 215
Pediatric patients with inflammatory bowel disease exhibit increased serum levels of proinflammatory cytokines and chemokines, but decreased circulating levels of macrophage inhibitory protein-1β, interleukin-2 and interleukin-17 215
To extinguish the fire from outside the cell or to shutdown the gas valve inside? Novel trends in anti-inflammatory therapies 214
Metabolic Syndrome and Psoriasis: Pivotal Roles of Chronic Inflammation and Gut Microbiota 206
Curcumin anti-apoptotic action in a model of intestinal epithelial inflammatory damage 200
Comments on ''Geranylgeraniol--a new potential therapeutic approach to bisphosphonate associated osteonecrosis of the jaw" by Ziebart T et al. (2011) 193
Two-gene mutation in a single patient: Biochemical and functional analysis for a correct interpretation of exome results 192
The complex interplay between lipids, immune system and interleukins in cardio-metabolic diseases 190
Autoinflammatory diseases and cytokine storms-imbalances of innate and adaptative immunity 186
Genistein exerts in vitro anti-inflammatory effects via NLRP3 modulation in a keratinocyte model 183
A common genetic background could explain early-onset Crohn's disease 180
Cytokine profiles of women with vulvodynia: Identification of a panel of pro-inflammatory molecular targets 179
Human skin volatilome: a pleiotropic tool to study inflammatory skin conditions 178
Innovative target therapies are able to block the inflammation associated with dysfunction of the cholesterol biosynthesis pathway 173
Putative modifier genes in mevalonate kinase deficiency 173
Alendronate, a double-edged sword acting in the mevalonate pathway 171
Mitochondria-Targeted Antioxidants, an Innovative Class of Antioxidant Compounds for Neurodegenerative Diseases: Perspectives and Limitations 164
Role of vitamin D in the pathogenesis of atheromatosis 163
Classical and Innovative Evidence for Therapeutic Strategies in Retinal Dysfunctions 162
Repositioning of Tak-475 in mevalonate kinase disease: Translating theory into practice 161
Mevalonate Kinase Deficiency and Neuroinflammation: Balance between Apoptosis and Pyroptosis 159
Comments to the editor concerning the paper entitled "Preclinical renal cancer chemopreventive efficacy of geraniol by modulation of multiple molecular pathways" Shiekh Tanveer Ahmad et al 158
Clinical Genetic Testing of Periodic Fever Syndromes 157
A comparative analysis of serologic parameters and oxidative stress in osteoarthritis and rheumatoid arthritis: reply to Mishra and colleagues 157
Ex vivo response to mucosal bacteria and muramyl dipeptide in inflammatory bowel disease 156
Altered germinal center reaction and abnormal B cell peripheral maturation in PI3KR1-mutated patients presenting with HIGM-like phenotype 153
Is autophagy an elective strategy to protect neurons from dysregulated cholesterol metabolism? 153
Database tools in genetic diseases research 150
Natural isoprenoids are able to reduce inflammation in a mouse model of mevalonate kinase deficiency 149
Mevalonate kinase deficiency: therapeutic targets, treatments, and outcomes 148
Rapid recovery of postnivolumab vemurafenib-induced Drug Rash with Eosinophilia and Systemic Symptoms (DRESS) syndrome after tocilizumab and infliximab administration 147
Block of the Mevalonate Pathway Triggers Oxidative and Inflammatory Molecular Mechanisms Modulated by Exogenous Isoprenoid Compounds 146
Convolvulus pluricaulis Choisy’s Extraction, Chemical Characterization and Evaluation of the Potential Effects on Glycaemic Balance in a 3T3-L1 Adipocyte Cell Model 143
The effect of clodronate on a mevalonate kinase deficiency cellular model 143
Lovastatin-induced apoptosis is modulated by geranylgeraniol in a neuroblastoma cell line 142
TRAIL administration down-modulated the acute systemic inflammatory response induced in a mouse model by muramyldipeptide or lipopolysaccharide 141
Curcumin and inflammatory bowel disease: Potential andlimits of innovative treatments 141
Acute Neurological Involvement after Donor Lymphocyte Infusion for Post-Transplant Viral Infection: The Same Pattern of Novel Cancer Immunotherapy-Related CNS Toxicity? 141
Lovastatin induces apoptosis through the mitochondrial pathway in an undifferentiated SH-SY5Y neuroblastoma cell line 133
Defect in mevalonate pathway induces pyroptosis in Raw 264.7 murine monocytes 131
Advantage of First-Line Therapeutic Drug Monitoring-Driven Use of Infliximab for Treating Acute Intestinal and Liver GVHD in Children: A Prospective, Single-Center Study 124
Microglia activation and interaction with neuronal cells in a biochemical model of mevalonate kinase deficiency 123
Prenylation Defects and Oxidative Stress Trigger the Main Consequences of Neuroinflammation Linked to Mevalonate Pathway Deregulation 121
Presence of IL-9 in paired samples of human colostrum and transitional milk 120
Inflammatory bowel disease and patterns of volatile organic compounds in the exhaled breath of children: A case-control study using Ion Molecule Reaction-Mass Spectrometry 118
Temperature and Drug Treatments in Mevalonate Kinase Deficiency: An Ex Vivo Study 112
Inflammation profile of four early onset Crohn patients 109
Mouse model of mevalonate kinase deficiency: comparison of cytokines and chemokines profile with human patients 109
Mevalonate Kinase Deficiency and Squalene Synthase Inhibitor (TAK-475): The Balance to Extinguish the Inflammation 107
Serum amyloid A and cholesterol: a pivotal role on inflammation 106
Defibrotide impact on the acute GVHD disease incidence in pediatric hematopoietic stem cell transplant recipients 105
Monocyte-predominant engraftment, cytokine levels and early transplant-related complications in pediatric hematopoietic stem cell recipients 105
Specific protein profile in cerebrospinal fluid from HIV-1-positive cART-treated patients affected by neurological disorders 105
Post-irradiation hyperamylasemia is a prognostic marker for allogeneic hematopoietic stem cell transplantation outcomes in pediatric population: A retrospective single-centre cohort analysis 105
New Mechanisms in Autoinflammatory Diseases 103
MitoQ is able to modulate apoptosis and inflammation 103
Decreased cholesterol levels reflect a consumption of anti-inflammatory isoprenoids associated with an impaired control of inflammation in a mouse model of mevalonate kinase deficiency 100
The farnesyltransferase inhibitors tipifarnib and lonafarnib inhibit cytokines secretion in a cellular model of mevalonate kinase deficiency 100
Clarification of the pleiotropic effects of statins on mevalonate pathway and the feedback regulation of isoprenoids requires more comprehensive investigation 100
Natural isoprenoids inhibit LPS-induced-production of cytokines and nitric oxide in aminobisphosphonate-treated monocytes 98
Mevalonate kinase deficiency and IBD: shared genetic background 98
Letter to the editor: acute effects of intravenous administration of pamidronate in patients with osteoporosis 97
New Applications of JAK/STAT Inhibitors in Pediatrics: Current Use of Ruxolitinib 95
Trained Immunity and Its Potential Implications in the Etiopathogenesis of Hidradenitis Suppurativa: A New Paradigm in Chronic Inflammation? 88
The Challenge of Next Generation Sequencing in a Boy with Severe Mononucleosis and EBV-related Lymphoma 88
Evolutionary hypothesis of the Mevalonate Kinase Deficiency 87
Farnesyl and geranylgeranyl transferase inhibitors: an anti-inflammatory effect. Comment to "Inhibition of protein geranylgeranylation and farnesylation protects against graft-versus-host disease via effects on CD4 effector T cells" Haematologica. 2013;98(1):31-40 85
Targeting farnesyl-transferase as a novel therapeutic strategy for mevalonate kinase deficiency: In vitro and in vivo approaches 84
Geraniol rescues inflammation in cellular and animal models of mevalonate kinase deficiency 83
Lysozyme-containing chitosan-coated arginate microspheres for oral immunisation 80
Letter: inflammatory bowel disease, complementary and alternative medicine, and genetics 78
Editorial: Advances in stem cell therapy: new applications and innovative therapeutic approaches 75
Standard treatment–refractory cytomegalovirus encephalitis unmasked by immune reconstitution inflammatory syndrome and successfully treated with virus-specific hyperimmune globulin 72
MIF plasma level as a possible tool to predict steroid responsiveness in children with idiopathic nephrotic syndrome 68
Long non-coding RNA GAS5 and intestinal MMP2 and MMP9 expression: A translational study in pediatric patients with IBD 65
Phytocompounds in Precision Dermatology: COX-2 Inhibitors as a Therapeutic Target in Atopic-Prone Skin 61
Mevalonate kinase deficiency: Disclosing the role of mevalonate pathway modulation in inflammation 61
Microcapsule a doppio strato di polisaccaridiutilizzabili come veicoli per la somministrazione oraledi sostanze biologicamente attive 56
Systemic and neuronal inflammatory markers in a mouse model of mevalonate kinase deficiency: a strain-comparative study 53
Family history in early-onset inflammatory bowel disease 52
Towards defining the chemical signature of inflammatory skin conditions: an in vitro model 36
TOWARDS DEFINING THE CHEMICAL SIGNATURE OF INFLAMMATORY SKIN CONDITIONS USING VOLATILE METABOLITES: AN IN VITRO MODEL 35
Targeting Intestinal Permeability for Graft-versus-Host Disease Treatment: A Therapeutic Perspective with Defibrotide 33
Exploratory Volatilome Profiling of Inflammation in Skin Fibroblasts: A Proof-of-Concept Study 13
Totale 11.864
Categoria #
all - tutte 67.340
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 67.340


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022448 0 36 15 12 11 49 41 40 20 71 22 131
2022/2023310 85 9 19 14 15 24 14 17 47 4 43 19
2023/2024373 33 38 28 9 32 22 20 22 16 20 18 115
2024/20251.776 27 37 168 67 218 158 56 67 266 316 279 117
2025/20265.518 422 388 474 766 720 288 484 332 517 654 264 209
2026/2027328 173 155 0 0 0 0 0 0 0 0 0 0
Totale 11.864